STOCKHOLM, October 3, 2013 /PRNewswire/ --
OxThera AB announces today that the FP7-project ELIMOX has started as of 1st of October, 2013. The primary aim of the project is to develop an innovative and unique bacterial pharmaceutical product for the treatment of a severe and......
More...
